Biological NI-1801 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

Light Chain Bioscience - Novimmune SA1

Indications

Pancreatic Adenocarcinoma (ductal Adenocarcinoma)1
Non-Squamous Non-Small Cell Lung Cancer1
Endometrioid Ovarian Cancer1
Triple Negative Breast Cancer1
Epithelial Ovarian Cancer1

Other1 trial

A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.